A comprehensive review of mRNA vaccines

V Gote, PK Bolla, N Kommineni, A Butreddy… - International journal of …, 2023 - mdpi.com
mRNA vaccines have been demonstrated as a powerful alternative to traditional
conventional vaccines because of their high potency, safety and efficacy, capacity for rapid …

Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management

VP Chavda, LK Vora, AK Pandya, VB Patravale - Drug discovery today, 2021 - Elsevier
Abstract Unlike conventional Coronavirus 2019 (COVID-19) vaccines, intranasal vaccines
display a superior advantage because the nasal mucosa is often the initial site of infection …

COVID-19: unmasking emerging SARS-CoV-2 variants, vaccines and therapeutic strategies

R Raman, KJ Patel, K Ranjan - Biomolecules, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of
the coronavirus disease 2019 (COVID-19) pandemic, which has been a topic of major …

Nanoparticle-based delivery systems for vaccines

R Bezbaruah, VP Chavda, L Nongrang, S Alom… - Vaccines, 2022 - mdpi.com
Vaccination is still the most cost-effective way to combat infectious illnesses. Conventional
vaccinations may have low immunogenicity and, in most situations, only provide partial …

[HTML][HTML] Nanomedicine for acute respiratory distress syndrome: the latest application, targeting strategy, and rational design

Q Qiao, X Liu, T Yang, K Cui, L Kong, C Yang… - … Pharmaceutica Sinica B, 2021 - Elsevier
Acute respiratory distress syndrome (ARDS) is characterized by the severe inflammation
and destruction of the lung air–blood barrier, leading to irreversible and substantial …

Lignin: drug/gene delivery and tissue engineering applications

R Kumar, A Butreddy, N Kommineni… - International Journal …, 2021 - Taylor & Francis
Lignin is an abundant renewable natural biopolymer. Moreover, a significant development in
lignin pretreatment and processing technologies has opened a new window to explore …

Nanotechnology-assisted metered-dose inhalers (MDIs) for high-performance pulmonary drug delivery applications

R Kumar, P Mehta, KR Shankar, MAK Rajora… - Pharmaceutical …, 2022 - Springer
Purpose Respiratory disorders pose a major threat to the morbidity and mortality to public
health. Here we reviewed the nanotechnology based pulmonary drug delivery using …

COVID-19 and vaccination: myths vs science

VP Chavda, Y Chen, J Dave, ZS Chen… - Expert Review of …, 2022 - Taylor & Francis
Introduction Several vaccines against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …

Antibacterial and antiviral high-performance nanosystems to mitigate new SARS-CoV-2 variants of concern

S Tiwari, S Juneja, A Ghosal, N Bandara… - Current Opinion in …, 2022 - Elsevier
The increased severity of the COVID-19 infection due to new SARS-CoV-2 variants has
resonated pandemic impact which made health experts to re-evaluate the effectiveness of …

Recent advances and challenges in gene delivery mediated by polyester-based nanoparticles

A Piperno, MT Sciortino, E Giusto… - International Journal …, 2021 - Taylor & Francis
Gene therapy is a promising approach for the treatment of several diseases, such as chronic
or viral infections, inherited disorders, and cancer. The cellular internalization of exogenous …